Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Marien

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Handbook of Experimental Pharmacology|September 23, 2010
Methylxanthines and ryanodine receptor channelsSerge Guerreiro, Marc Marien, Patrick P Michel
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2002
Effects of acute and subchronic administration of dexefaroxan, an alpha(2)-adrenoceptor antagonist, on memory performance in young adult and aged rodentsPhilippe Chopin, Francis C Colpaert, Marc Marien
Receptors & Channels|October 7, 2003
Effects of (+/-)-idazoxan alone and in combination with L-DOPA methyl ester in MPTP-induced hemiparkinsonian monkeysEdward F Domino, Lisong Ni, Francis Colpaert, et al.
Learning & Memory (Cold Spring Harbor, N.Y.)|December 19, 2007
Noradrenergic control of odor recognition in a nonassociative olfactory learning task in the mouseAlexandra Veyrac, Véronique Nguyen, Marc Marien, et al.
Experimental Neurology|July 19, 2005
Activation of noradrenergic transmission by alpha2-adrenoceptor antagonists counteracts deafferentation-induced neuronal death and cell proliferation in the adult mouse olfactory bulbAlexandra Veyrac, Anne Didier, Francis Colpaert, et al.
Brain Research|December 13, 2003
The PARP inhibitor benzamide protects against kainate and NMDA but not AMPA lesioning of the mouse striatum in vivoCristina Cosi, Karen Guerin, Marc Marien, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 24, 2008
Novelty determines the effects of olfactory enrichment on memory and neurogenesis through noradrenergic mechanismsAlexandra Veyrac, Joëlle Sacquet, Véronique Nguyen, et al.
Molecular Pharmacology|March 30, 2006
The phenotypic differentiation of locus ceruleus noradrenergic neurons mediated by brain-derived neurotrophic factor is enhanced by corticotropin releasing factor through the activation of a cAMP-dependent signaling pathwaySabine Traver, Marc Marien, Elodie Martin, et al.
Molecular Pharmacology|July 16, 2008
Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channelsSerge Guerreiro, Damien Toulorge, Etienne Hirsch, et al.
Journal of Medicinal Chemistry|September 3, 2010
Rigid analogues of the α2-adrenergic blocker atipamezole: small changes, big consequencesBernard Vacher, Philippe Funes, Philippe Chopin, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Handbook of Experimental Pharmacology|September 23, 2010
Methylxanthines and ryanodine receptor channelsSerge Guerreiro, Marc Marien, Patrick P Michel
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2002
Effects of acute and subchronic administration of dexefaroxan, an alpha(2)-adrenoceptor antagonist, on memory performance in young adult and aged rodentsPhilippe Chopin, Francis C Colpaert, Marc Marien
Receptors & Channels|October 7, 2003
Effects of (+/-)-idazoxan alone and in combination with L-DOPA methyl ester in MPTP-induced hemiparkinsonian monkeysEdward F Domino, Lisong Ni, Francis Colpaert, et al.
Learning & Memory (Cold Spring Harbor, N.Y.)|December 19, 2007
Noradrenergic control of odor recognition in a nonassociative olfactory learning task in the mouseAlexandra Veyrac, Véronique Nguyen, Marc Marien, et al.
Experimental Neurology|July 19, 2005
Activation of noradrenergic transmission by alpha2-adrenoceptor antagonists counteracts deafferentation-induced neuronal death and cell proliferation in the adult mouse olfactory bulbAlexandra Veyrac, Anne Didier, Francis Colpaert, et al.
Brain Research|December 13, 2003
The PARP inhibitor benzamide protects against kainate and NMDA but not AMPA lesioning of the mouse striatum in vivoCristina Cosi, Karen Guerin, Marc Marien, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 24, 2008
Novelty determines the effects of olfactory enrichment on memory and neurogenesis through noradrenergic mechanismsAlexandra Veyrac, Joëlle Sacquet, Véronique Nguyen, et al.
Molecular Pharmacology|March 30, 2006
The phenotypic differentiation of locus ceruleus noradrenergic neurons mediated by brain-derived neurotrophic factor is enhanced by corticotropin releasing factor through the activation of a cAMP-dependent signaling pathwaySabine Traver, Marc Marien, Elodie Martin, et al.
Molecular Pharmacology|July 16, 2008
Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channelsSerge Guerreiro, Damien Toulorge, Etienne Hirsch, et al.
Journal of Medicinal Chemistry|September 3, 2010
Rigid analogues of the α2-adrenergic blocker atipamezole: small changes, big consequencesBernard Vacher, Philippe Funes, Philippe Chopin, et al.
Pageof 3